Patient who was hospitalized after receiving Intellia’s CRISPR therapy dies
在接受英特利亚治疗公司的CRISPR疗法后住院的患者去世

A man in his early 80s who was recently hospitalized with liver injury a few weeks after receiving an experimental gene editing therapy died on Wednesday night.
一名年逾80岁的男子在接受一项实验性基因编辑疗法后数周因肝损伤入院，已于周三晚间去世。